Biomedical Engineering Reference
In-Depth Information
pulmonary disease. NHLBI
=
WHO Global Initiative for Chronic Obstructive
Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med
2001; 163:1256-1276.
62. Peinado VI, Barber
`
JA, Abate P, Ramirez J, Roca J, Santos S, Rodriguez-
Roisin R. Inflammatory reaction in pulmonary muscular arteries of patients
with mild chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 1999; 159:1605-1611.
63. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in
bronchial biopsies of subjects with chronic bronchitis: inverse relationship
of CD8
þ
T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155:
852-857.
64. Saetta M, Di-Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, et al.
CD8
þ
T-lymphocytes in peripheral airways of smokers with chronic obstruc-
tive pulmonary disease. Am J Respir Crit Care Med 1998; 157:822-826.
65. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, et al.
Amplification of inflammation in emphysema and its association with latent
adenoviral infection. Am J Respir Crit Care Med 2001; 164:469-473.
66. Miller LG, Goldstein G, Murphy M, Ginns LC. Reversible alterations in
immunoregulatory T cells in smoking. Analysis by monoclonal antibodies
and flow cytometry. Chest 1982; 82:526-529.
67. Costabel U, Bross KJ, Reuter C, Ruhle KH, Matthys H. Alterations in immu-
noregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of
bronchoalveolar and blood lymphocytes. Chest 1986; 90:39-44.
68. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S,
Hirth PK, Waltenberger J, Voelkel NF. Inhibition of VEGF receptors causes
lung cell apoptosis and emphysema. J Clin Invest 2000; 106:1311-1319.
69. Grosskreutz CL, Anand-Apte B, Duplaa C, Quinn TP, Terman Bl, Zetter B,
D'Amore PA. Vascular endothelial growth factor-induced migration of vascu-
lar smooth muscle cells in vitro. Microvasc Res 1999; 58:128-136.
70. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors.
Nat Med 2003; 9:669-676.
71. Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara
Y, et al. Expression of angiogenesis-related molecules in plexiform lesions in
severe pulmonary hypertension: evidence for a process of disordered angio-
genesis. J Pathol 2001; 195:367-374.
72. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF.
Endothelial cell death and decreased expression of vascular endothelial growth
factor and vascular endothelial growth factor receptor 2 in emphysema. Am J
Respir Crit Care Med 2001; 163:737-744.
73. Voelkel NF, Cool C, Taraceviene-Stewart L, Geraci MW, Yeager M, Bull T,
Kasper M, Tuder RM. Janus face of vascular endothelial growth factor: the
obligatory survival factor for lung vascular endothelium controls precapillary
artery remodeling in severe pulmonary hypertension. Crit Care Med 2002;
30:S251-S256.
74. Wang H, Keiser JA. Vascular endothelial growth factor upregulates the
expression of matrix metalloproteinases in vascular smooth muscle cells: role
of flt-1. Circ Res 1998; 83:832-840.
